Viewing StudyNCT06161558



Ignite Creation Date: 2024-05-06 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:15 PM
Study NCT ID: NCT06161558
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-15
First Post: 2023-12-07

Brief Title: Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-18
Start Date Type: ESTIMATED
Primary Completion Date: 2027-01-05
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-11-16
Completion Date Type: ESTIMATED
First Submit Date: 2023-12-07
First Submit QC Date: December 7 2023
Study First Post Date: 2023-12-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-23
Last Update Post Date: 2024-07-15
Last Update Post Date Type: ESTIMATED